HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients

AIDS and Behavior

Volumn 16, Issue 6, 2012, Pages 1681-1689

  Sumari De Boer, I Marion ^a   Sprangers, Mirjam A G ^a   Prins, Jan M ^a   Nieuwkerk, Pythia T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; cART; Depressive symptoms; HIV stigma; Immigrants; Virological response

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; DEPRESSION; DRUG EFFECT; ETHNOLOGY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; METHODOLOGY; MIDDLE AGED; MIGRATION; NETHERLANDS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SOCIAL STIGMA; SOCIAL SUPPORT; STATISTICS; VIROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEPRESSION; EMIGRANTS AND IMMIGRANTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SOCIAL STIGMA; SOCIAL SUPPORT; VIRAL LOAD; YOUNG ADULT;

EID: 84865161350     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0112-y     Document Type: Article

References (59)

1. DR Bangsberg 2006 Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression Clin Infect Dis 43 7 939 941 16941380 10.1086/507526 1:CAS:528:DC%2BD28XhtVKhsrbP (Pubitemid 44435526)
2. DL Paterson S Swindells J Mohr M Brester EN Vergis C Squier, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 1 21 30 10877736 1:STN:280:DC%2BD3czit1altA%3D%3D (Pubitemid 30432540)
3. R Gross B Yip V Lo Re III E Wood CS Alexander PR Harrigan, et al. 2006 A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression J Infect Dis 194 8 1108 1114 16991085 10.1086/507680 (Pubitemid 44547650)
4. V Cambiano FC Lampe AJ Rodger CJ Smith AM Geretti RK Lodwick, et al. 2010 Long-term trends in adherence to antiretroviral therapy from start of HAART AIDS 24 8 1153 1162 20299959 10.1097/QAD.0b013e32833847af 1:CAS:528: DC%2BC3cXlsVOmsb0%3D
5. Md Bruin HJ Hospers GJ van Breukelen G Kok WM Koevoets JM Prins 2010 Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial Health Psychol 29 4 421 428 20658830 10.1037/a0020335
6. UNAIDS. Report on the global HIV/AIDS epidemic 2008. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008; 2008.
7. JB van den Berg E Hak SC Vervoort IM Hoepelman CA Boucher R Schuurman, et al. 2005 Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy HIV Med 6 5 299 306 16156876 10.1111/j.1468-1293.2005.00304.x (Pubitemid 41335137)
8. JF Nellen FW Wit WF De S Jurriaans JM Lange JM Prins 2004 Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands J Acquir Immune Defic Syndr 36 4 943 950 15220701 10.1097/00126334-200408010-00008 (Pubitemid 38944090)
9. R Dray-Spira B Spire I Heard F Lert 2007 Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study AIDS 21 Suppl 1 S5 S12 17159588 10.1097/01.aids. 0000255079.39352.9b
10. SM Barry SJ Lloyd-Owen SJ Madge, et al. 2002 The changing demographics of new HIV diagnosis at a London centre from 1994 to 2000 HIV Med 3 129 134 12010360 10.1046/j.1468-1293.2002.00103.x 1:STN:280:DC%2BD38zhtlCitg%3D%3D (Pubitemid 34567584)
11. R Grossberg Y Zhang R Gross 2004 A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV J Clin Epidemiol 57 10 1107 1110 15528063 10.1016/j.jclinepi.2004.04.002 (Pubitemid 39451804)
12. F Maggiolo L Ravasio D Ripamonti G Gregis G Quinzan C Arici, et al. 2005 Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors Clin Infect Dis 40 1 158 163 15614706 10.1086/426595 1:CAS:528:DC%2BD2MXmslGgsQ%3D%3D (Pubitemid 40053474)
13. M Martin E del Cacho C Codina M Tuset E de Lazzari J Mallolas, et al. 2008 Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study AIDS Res Hum Retroviruses 24 10 1263 1268 18834323 10.1089/aid.2008.0141 1:CAS:528: DC%2BD1cXht1ent7rL
14. JB Nachega M Hislop DW Dowdy RE Chaisson L Regensberg G Maartens 2007 Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes Ann Intern Med 146 8 564 573 17438315 (Pubitemid 351650537)
15. ML Townsend GL Jackson R Smith KH Wilson 2007 Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: a retrospective analysis in treatment-experienced adults with HIV Clin Ther 29 4 711 716 17617294 10.1016/j.clinthera.2007.04.006 (Pubitemid 47016639)
16. S Mannheimer G Friedland J Matts C Child M Chesney 2002 The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials Clin Infect Dis 34 8 1115 1121 11915001 10.1086/339074 (Pubitemid 34289685)
17. A Ammassari MP Trotta R Murri F Castelli P Narciso P Noto, et al. 2002 Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature J Acquir Immune Defic Syndr 31 Suppl 3 S123 S127 12562034
18. N Singh SM Berman S Swindells JC Justis JA Mohr C Squier, et al. 1999 Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy Clin Infect Dis 29 4 824 830 10589897 10.1086/520443 1:STN:280:DC%2BD3c%2FlsFynsA%3D%3D (Pubitemid 30256376)
19. JF Nellen PT Nieuwkerk DM Burger M Wibaut LA Gras JM Prins 2009 Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients? AIDS Care 21 7 842 850 20024740 10.1080/09540120802612816
20. Nellen F, Bruin MD, Kreyenbroek M, Stronks K, Prins JM. Perceptions on HIV infection and treatment in ethnic Dutch and non-ethnic-Dutch HIV-1 infected patients: qualitative interview study. In: Nellen F, editor. Highly active antiretroviral therapy in non-indigenous patients in the Netherlands. Amsterdam: University of Amsterdam; 2007. p. 57-70.
21. SE Stutterheim JB Pryor AE Bos R Hoogendijk P Muris HP Schaalma 2009 HIV-related stigma and psychological distress: the harmful effects of specific stigma manifestations in various social settings AIDS 23 17 2353 2357 19741478 10.1097/QAD.0b013e3283320dce
22. MR DiMatteo HS Lepper TW Croghan 2000 Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med 160 14 2101 2107 10904452 10.1001/archinte.160.14.2101 1:STN:280:DC%2BD3czptVKgug%3D%3D (Pubitemid 30482715)
23. WC Holmes WB Bilker H Wang J Chapman R Gross 2007 HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time J Acquir Immune Defic Syndr 46 3 323 327 17846560 10.1097/QAI.0b013e31815724fe (Pubitemid 350287360)
24. A Ammassari R Murri P Pezzotti MP Trotta L Ravasio LP De, et al. 2001 Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection J Acquir Immune Defic Syndr 28 5 445 449 11744832 1:CAS:528:DC%2BD38XltVKkug%3D%3D (Pubitemid 34033195)
25. A Mahajan J Sayles V Patel R Remien S Sawires D Ortiz, et al. 2008 Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward AIDS 22 Suppl 2 S67 S79 18641472 10.1097/01.aids.0000327438. 13291.62
26. K Whetten S Reif R Whetten LK Murphy-McMillan 2008 Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care Psychosom Med 70 5 531 538 18541904 10.1097/PSY.0b013e31817749dc
27. R Cardarelli S Weis E Adams D Radaford I Vecino G Munguia, et al. 2008 General health status and adherence to antiretroviral therapy J Int Assoc Physicians AIDS Care (Chic Ill) 7 3 123 129 10.1177/1545109708318526
28. M Horberg M Silverberg L Hurley W Towner D Klein S Bersoff-Matcha, et al. 2008 Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients J Acquir Immune Defic Syndr 47 3 384 390 18091609 10.1097/QAI.0b013e318160d53e 1:CAS:528:DC%2BD1cXjt1enu7k%3D (Pubitemid 351619427)
29. D Kacanek DL Jacobson D Spiegelman C Wanke R Isaac IB Wilson 2010 Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study J Acquir Immune Defic Syndr 53 2 266 272 20104122 10.1097/QAI.0b013e3181b720e7
30. AM Vranceanu SA Safren M Lu WM Coady PR Skolnik WH Rogers, et al. 2008 The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV AIDS Patient Care STDS 22 4 313 321 18338960 10.1089/apc.2007.0069 (Pubitemid 351562964)
31. B Spire S Duran M Souville C Leport F Raffi JP Moatti 2002 Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach Soc Sci Med 54 10 1481 1496 12061483 10.1016/S0277-9536(01)00125-3 (Pubitemid 34309013)
32. C Protopopescu F Raffi P Roux J Reynes P Dellamonica B Spire, et al. 2009 Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data J Antimicrob Chemother 64 3 599 606 19602563 10.1093/jac/dkp232 1:CAS:528:DC%2BD1MXhtVWju7jI
33. IM der Kolk MA Sprangers MV Ende G Schreij FD Wolf PT Nieuwkerk 2008 Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort J Acquir Immune Defic Syndr 49 4 460 462 10.1097/QAI.0b013e318186eefe
34. R Horne D Buick M Fisher H Leake V Cooper J Weinman 2004 Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART Int J STD AIDS 15 1 38 44 14769170 10.1258/095646204322637245 (Pubitemid 38096128)
35. R Horne V Cooper G Gellaitry HL Date M Fisher 2007 Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework J Acquir Immune Defic Syndr 45 3 334 341 17514019 (Pubitemid 47012382)
36. R Horne L Graupner S Frost J Weinman SM Wright M Hankins 2004 Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications Soc Sci Med 59 6 1307 1313 15210101 10.1016/j.socscimed.2004.01.009 (Pubitemid 38759888)
37. Gras L, Sighem Av, Smit C, Zaheri S, Schuitemaker H, Wolf Fd, et al. Monitoring of Human Immunodeficiency Virus (HIV) infection in the Netherlands: Report 2009. Amsterdam: HIV Monitoring Foundation; 2009.
38. B Lichtenstein MK Laska JM Clair 2002 Chronic sorrow in the HIV-positive patient: issues of race, gender, and social support AIDS Patient Care STDS 16 27 38 11839216 10.1089/108729102753429370 (Pubitemid 34118920)
39. AW Wu DA Revicki D Jacobson FE Malitz 1997 Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) Qual Life Res 6 6 481 493 9330549 10.1023/A:1018451930750 1:STN:280:DyaK2svntFKjug%3D%3D (Pubitemid 27431704)
40. B Berger C Ferrans F Lashley 2001 Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale Res Nurs Health 24 6 518 529 11746080 10.1002/nur.10011 1:STN:280:DC%2BD3MnpslensQ%3D%3D (Pubitemid 33604361)
41. J Bunn S Solomon C Miller R Forehand 2007 Measurement of stigma in people with HIV: a reexamination of the HIV stigma scale AIDS Educ Prev 19 3 198 208 17563274 10.1521/aeap.2007.19.3.198 (Pubitemid 46911568)
42. IM de Boer JM Prins MAG Sprangers PT Nieuwkerk 2010 Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patients J Acquir Immune Defic Syndr 55 635 640 21934556 10.1097/QAI.0b013e3181fba6ab
43. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1 105 116 9048695 10.1016/S0895-4356(96)00268-5 1:STN:280:DyaK2s3gtVyltA%3D%3D (Pubitemid 27089212)
44. RM Baron DA Kenny 1986 The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations J Pers Soc Psych 51 6 1173 1182 10.1037/0022-3514.51.6.1173 1:STN:280:DyaL2s7ht1SrsQ%3D%3D
45. KJ Preacher AF Hayes 2008 Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models Behav Res Methods 40 879 891 18697684 10.3758/BRM.40.3.879
46. Preacher KJ, Hayes AF.: SPSS macro for multiple mediation written by Andrew F. Hayes. The Ohio State University. http://www.afhayes.com/spss-sas-and- mplus-macros-and-code.html. Accessed 8 Sept 2011.
47. BS Gerber YI Cho AM Arozullah SY Lee 2010 Racial differences in medication adherence: a cross-sectional study of Medicare enrollees Am J Geriatr Pharmacother 8 2 136 145 20439063 10.1016/j.amjopharm.2010.03.002
48. BR Schackman HJ Ribaudo A Krambrink V Hughes DR Kuritzkes RM Gulick 2007 Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095 J Acquir Immune Defic Syndr 46 5 547 554 18193496 10.1097/QAI. 0b013e31815ac499 1:CAS:528:DC%2BD2sXhtlGht73E (Pubitemid 350191047)
49. Simoni JM, Goggin K, Reynolds NR, Wilson IB, Remien R, Bangsberg DR, et al. Is race/ethnicity associated with ART adherence? Findings from the MACH14 Study. In: 5th international conference on HIV treatment adherence; 2010.
50. PT Nieuwkerk IM der Kolk JM Prins M Locadia MA Sprangers 2010 Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding Antivir Ther 15 6 913 916 20834104 10.3851/IMP1644 1:CAS:528:DC%2BC3cXhtlWjsLbN
51. F Starace A Ammassari MP Trotta R Murri LP De C Izzo, et al. 2002 Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy J Acquir Immune Defic Syndr 31 Suppl 3 S136 S139 12562037
52. Rao D, Feldman BJ, Fredericksen RJ, et al. A structural equation model of HIV related stigma, depressive symptoms, and medication adherence. AIDS Behav. 2011. doi: 10.1007/s10461-011-9915-0.
53. JD Hartzell IE Janke AC Weintrob 2008 Impact of depression on HIV outcomes in the HAART era J Antimicrob Chemother 62 2 246 255 18456650 10.1093/jac/dkn193 1:CAS:528:DC%2BD1cXosVOgsLk%3D (Pubitemid 351984767)
54. JR Ickovics ME Hamburger D Vlahov EE Schoenbaum P Schuman RJ Boland, et al. 2001 Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study JAMA 285 11 1466 1474 11255423 10.1001/jama.285.11.1466 1:STN:280:DC%2BD3M7osFCmtA%3D%3D (Pubitemid 32221895)
55. V Villes B Spire C Lewden C Perronne JM Besnier M Garre, et al. 2007 The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice Antivir Ther 12 7 1067 1074 18018765 (Pubitemid 350114987)
56. C Emlet 2007 Experiences of stigma in older adults living with HIV/AIDS: a mixed-methods analysis AIDS Patient Care STDs 21 10 740 752 17949273 10.1089/apc.2007.0010 (Pubitemid 47614387)
57. PT Nieuwkerk FJ Oort 2005 Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis J Acquir Immune Defic Syndr 38 4 445 448 15764962 10.1097/01.qai.0000147522.34369. 12 (Pubitemid 40381555)
58. JM Simoni CR Pearson DW Pantalone G Marks N Crepaz 2006 Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials J Acquir Immune Defic Syndr 43 Suppl 1 S23 S35 17133201
59. MC Garber DP Nau SR Erickson JE Aikens JB Lawrence 2004 The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 7 649 652 15213489 10.1097/01.mlr.0000129496.05898.02